0001104659-22-061934.txt : 20220517 0001104659-22-061934.hdr.sgml : 20220517 20220517160559 ACCESSION NUMBER: 0001104659-22-061934 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220514 FILED AS OF DATE: 20220517 DATE AS OF CHANGE: 20220517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gagnon Robert E. CENTRAL INDEX KEY: 0001504983 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35403 FILM NUMBER: 22934466 MAIL ADDRESS: STREET 1: C/O BIOGEN IDEC INC. STREET 2: 133 BOSTON POST ROAD CITY: WESTON STATE: MA ZIP: 02493 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verastem, Inc. CENTRAL INDEX KEY: 0001526119 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273269467 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 117 KENDRICK STREET STREET 2: SUITE 500 CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: (781) 292-4200 MAIL ADDRESS: STREET 1: 117 KENDRICK STREET STREET 2: SUITE 500 CITY: NEEDHAM STATE: MA ZIP: 02494 4 1 tm2215781-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-05-14 0 0001526119 Verastem, Inc. VSTM 0001504983 Gagnon Robert E. C/O VERASTEM, INC., 117 KENDRICK ST., SUITE 500 NEEDHAM MA 02494 0 1 0 0 Chief Financial Officer Common Stock 2022-05-14 4 A 0 50000 0.00 A 607880 D Common Stock 2022-05-16 4 S 0 16627 1.03 D 591253 D Represents performance-based restricted stock units ("PRSUs") granted to the Reporting Person on June 24, 2021 under the Issuer's 2021 Equity Incentive Plan. Each PRSU represents the right to receive one share of Common Stock. On May 14, 2022 the Compensation Committee of the Issuer's Board of Directors certified that the PRSUs' performance criteria had been satisfied and the PRSUs vested in full. The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. /s/ Robert E. Gagnon 2022-05-17